Vulvar Melanoma, also known as malignant melanoma of vulva, is related to vulva cancer and amelanotic melanoma, and has symptoms including dysuria and pruritus. An important gene associated with Vulvar Melanoma is MIR19B1 (MicroRNA 19b-1), and among its related pathways/superpathways are Signal Transduction and MAPK-Erk Pathway. The drugs Nivolumab and Immune Checkpoint Inhibitors have been mentioned in the context of this disorder. Affiliated tissues include lymph node and skin, and related phenotypes are homeostasis/metabolism and growth/size/body region